These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9260236)

  • 21. An open label non-inferiority randomized controlled trial evaluated alternate day prednisolone given daily during infections vs. levamisole in frequently relapsing nephrotic syndrome.
    Sinha A; Devi KG; Kalra S; Mani K; Hari P; Bagga A
    Kidney Int; 2024 May; 105(5):1113-1123. PubMed ID: 38360110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Levamisole vs. cyclophosphamide for frequently-relapsing steroid-dependent nephrotic syndrome.
    Alsaran K; Grisaru S; Stephens D; Arbus G
    Clin Nephrol; 2001 Oct; 56(4):289-94. PubMed ID: 11680658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term results of two unconventional agents in steroid-dependent nephrotic children.
    Donia AF; Ammar HM; El-Agroudy Ael-B; Moustafa Fel-H; Sobh MA
    Pediatr Nephrol; 2005 Oct; 20(10):1420-5. PubMed ID: 16047223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Levamisole treatment in steroid-sensitive and steroid-resistant nephrotic syndrome.
    Tenbrock K; Müller-Berghaus J; Fuchshuber A; Michalk D; Querfeld U
    Pediatr Nephrol; 1998 Aug; 12(6):459-62. PubMed ID: 9745868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Levamisole for corticosteroid-dependent nephrotic syndrome in childhood. British Association for Paediatric Nephrology.
    Lancet; 1991 Jun; 337(8757):1555-7. PubMed ID: 1675705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Difficult-to-treat nephrotic syndrome: management and outcome.
    Sumboonnanonda A; Chongchate N; Suntornpoch V; Pattaragarn A; Supavekin S
    J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S142-8. PubMed ID: 16856434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Population pharmacokinetics of levamisole in children with steroid-sensitive nephrotic syndrome.
    Kreeftmeijer-Vegter AR; Dorlo TP; Gruppen MP; de Boer A; de Vries PJ
    Br J Clin Pharmacol; 2015 Aug; 80(2):242-52. PubMed ID: 25677380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term efficacy and safety of common steroid-sparing agents in idiopathic nephrotic children.
    Basu B; Babu BG; Mahapatra TK
    Clin Exp Nephrol; 2017 Feb; 21(1):143-151. PubMed ID: 27108294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short- and long-term efficacy of levamisole as adjunctive therapy in childhood nephrotic syndrome.
    Boyer O; Moulder JK; Grandin L; Somers MJ
    Pediatr Nephrol; 2008 Apr; 23(4):575-80. PubMed ID: 18204939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Levamisole in steroid-sensitive nephrotic syndrome children with steroid-dependency and/or frequent relapses.
    Fu LS; Chi CS
    Acta Paediatr Taiwan; 2000; 41(2):80-4. PubMed ID: 10927944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of relapses with levamisole as adjuvant therapy in children with a first episode of idiopathic nephrotic syndrome: study protocol for a double blind, randomised placebo-controlled trial (the LEARNS study).
    Veltkamp F; Khan DH; Reefman C; Veissi S; van Oers HA; Levtchenko E; Mathôt RAA; Florquin S; van Wijk JAE; Schreuder MF; Haverman L; Bouts AHM
    BMJ Open; 2019 Aug; 9(8):e027011. PubMed ID: 31375606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-corticosteroid treatment for nephrotic syndrome in children.
    Durkan A; Hodson E; Willis N; Craig J
    Cochrane Database Syst Rev; 2001; (4):CD002290. PubMed ID: 11687155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Short-term efficacy of rituximab versus tacrolimus in steroid-dependent nephrotic syndrome.
    Sinha A; Bagga A; Gulati A; Hari P
    Pediatr Nephrol; 2012 Feb; 27(2):235-41. PubMed ID: 21922213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adrenocortical suppression increases the risk of relapse in nephrotic syndrome.
    Abeyagunawardena AS; Hindmarsh P; Trompeter RS
    Arch Dis Child; 2007 Jul; 92(7):585-8. PubMed ID: 17284479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Levamisole in steroid-sensitive nephrotic syndrome of childhood: the lost paradise?
    Davin JC; Merkus MP
    Pediatr Nephrol; 2005 Jan; 20(1):10-4. PubMed ID: 15378419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment with mycophenolate mofetil and prednisolone for steroid-dependent nephrotic syndrome.
    Afzal K; Bagga A; Menon S; Hari P; Jordan SC
    Pediatr Nephrol; 2007 Dec; 22(12):2059-65. PubMed ID: 17938973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recurrence of severe steroid dependency in cyclosporin A-treated childhood idiopathic nephrotic syndrome.
    Kemper MJ; Kuwertz-Broeking E; Bulla M; Mueller-Wiefel DE; Neuhaus TJ
    Nephrol Dial Transplant; 2004 May; 19(5):1136-41. PubMed ID: 14993510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Levamisole in children with frequently recurring idiopathic nephrotic syndrome].
    Meregalli P; Bianchetti MG; Imoberdorf G; Lütschg J; Reymond D; Oetliker OH
    Schweiz Med Wochenschr; 1994 May; 124(19):801-5. PubMed ID: 8209202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Levamisole in children's idiopathic nephrotic syndrome.
    La Manna A; Polito C; Del Gado R; Foglia AC
    Child Nephrol Urol; 1988-1989; 9(4):200-2. PubMed ID: 3255483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Short- and long-term efficacy of levamisole in children with steroid-sensitive nephrotic syndrome.
    Elmas AT; Tabel Y; Elmas ON
    Int Urol Nephrol; 2013 Aug; 45(4):1047-55. PubMed ID: 22826143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.